DN
David Nierengarten Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
51
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
78.6%
Neutral
19.6%
Negative
1.8%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Technology
Consumer Discretionary
Residential Construction
Restaurants
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
Technology
Solar
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $95 |
39%
upside
| 1 | -3.4% |
0
%
| 3 Mar ‘26 22 hours ago |
|
|
|
Outperform
Maintained
| $65 |
139%
upside
| 1 | -16% |
0
%
| 25 Feb ‘26 7 days ago |
|
|
|
Outperform
Maintained
| $53 |
17%
upside
| 4 | +24% |
0
%
| 25 Feb ‘26 7 days ago |
|
|
|
Outperform
Reiterated
| $20 |
48%
upside
| 3 | +8.8% |
0
%
| 24 Feb ‘26 7 days ago |
|
|
|
Underperform
Initiated
| $110 |
1%
downside
| 1 | +16% |
0
%
| 24 Feb ‘26 7 days ago |
|
|
|
Outperform
Maintained
| $88 |
37%
upside
| 2 | -4.9% |
0
%
| 17 Feb ‘26 14 days ago |
|
|
|
Outperform
Reiterated
| $11 |
152%
upside
| 5 | +18% |
0
%
| 10 Feb ‘26 21 days ago |
|
|
|
Outperform
Reiterated
| $11 |
113%
upside
| 3 | +32% |
0
%
| 30 Jan ‘26 1 month ago |
|
|
|
Outperform
Reiterated
| $55 |
48%
upside
| 1 | -6.7% |
0
%
| 21 Jan ‘26 1 month ago |
|
|
|
Outperform
Reiterated
| $31 |
44%
upside
| 2 | +73% |
0
%
| 15 Jan ‘26 1 month ago |
|
|
|
Neutral
Reiterated
| $18 |
35%
upside
| 2 | – |
–
| 15 Jan ‘26 1 month ago |
|
|
|
Outperform
Reiterated
| $1,000 |
34%
upside
| 7 | +6.1% |
0
%
| 14 Jan ‘26 1 month ago |
|
|
|
Outperform
Reiterated
| $30 |
67%
upside
| 1 | +2.8% |
0
%
| 13 Jan ‘26 1 month ago |
|
|
|
Outperform
Upgraded
| $5.50 | – | 2 | +6.5% |
0
%
| 16 Dec ‘25 2 months ago |
|
|
|
Outperform
Reiterated
| $25 |
157%
upside
| 3 | -1.4% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $7 |
49%
downside
| 2 | – |
–
| 7 Nov ‘25 3 months ago |
|
|
|
Outperform
Upgraded
| $7 |
411%
upside
| 2 | -17% |
0
%
| 27 Oct ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $70 |
33%
upside
| 1 | +66% |
0
%
| 15 Oct ‘25 4 months ago |
|
|
|
Outperform
Reiterated
| $115 |
15%
upside
| 1 | +24% |
0
%
| 8 Sep ‘25 5 months ago |
|
|
|
Outperform
Initiated
| $4 |
5%
downside
| 1 | +173% |
0
%
| 8 Sep ‘25 5 months ago |
|
|
|
Outperform
Reiterated
| $26 |
116%
upside
| 2 | +28% |
0
%
| 2 Sep ‘25 6 months ago |
|
|
|
Outperform
Reiterated
| $22 |
216%
upside
| 3 | -25% |
0
%
| 28 Aug ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $276 |
4,417%
upside
| 1 | – |
–
| 25 Jul ‘25 7 months ago |
|
|
|
Neutral
Reiterated
| $8 |
46%
downside
| 1 | – |
–
| 26 Jun ‘25 8 months ago |
|
|
|
Neutral
Downgraded
| $129 |
0%
downside
| 2 | +24% |
0
%
| 2 Jun ‘25 9 months ago |
|